Sandoz's Q3 Sales Rise; Outlook Updated

02:24 AM EDT, 10/28/2026 (MT Newswires) -- Sandoz Group (SDZ.SW) logged a 5% year-over-year growth in constant-currency net sales for the third quarter, a Wednesday filing showed. For the three months ended Sept. 30, net sales were $2.94 billion versus $2.83 billion previously, the Switzerland-listed drugmaker said. For 2026, the group revised its constant-currency net sales growth outlook to between 5% and 6%, from the previous guidance of mid-to-high single-digit growth.